Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	4.69e-10	38	50	6	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	4.82e-07	118	50	6	GO:0003774
GeneOntologyMolecularFunction	actin filament binding	MYH1 MYH2 MYH4 MYH13 XIRP2 MYO9B MYO10	1.47e-06	227	50	7	GO:0051015
GeneOntologyMolecularFunction	ATP-dependent activity	MYH1 MYH2 MYH4 MYH13 MCM8 MYO9B MYO10 RAD54B TAP1	1.88e-05	614	50	9	GO:0140657
GeneOntologyMolecularFunction	calmodulin binding	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	2.28e-05	230	50	6	GO:0005516
GeneOntologyMolecularFunction	actin binding	MYH1 MYH2 MYH4 MYH13 XIRP2 MYO9B MYO10	1.79e-04	479	50	7	GO:0003779
GeneOntologyMolecularFunction	protein kinase regulator activity	MOB1B MOB1A RICTOR TRIB1 ELP4	4.65e-04	259	50	5	GO:0019887
GeneOntologyMolecularFunction	MHC class Ib protein binding	LILRB2 TAP1	7.21e-04	16	50	2	GO:0023029
GeneOntologyMolecularFunction	kinase regulator activity	MOB1B MOB1A RICTOR TRIB1 ELP4	9.71e-04	305	50	5	GO:0019207
GeneOntologyMolecularFunction	protein serine/threonine kinase activator activity	MOB1B MOB1A RICTOR	9.85e-04	78	50	3	GO:0043539
GeneOntologyMolecularFunction	MHC class I protein binding	LILRB2 TAP1	2.91e-03	32	50	2	GO:0042288
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH2 MYH4 MYO9B	1.00e-05	18	49	3	GO:0033275
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	4.95e-09	59	49	6	GO:0016459
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH4 MYH13	4.75e-08	16	49	4	GO:0005859
GeneOntologyCellularComponent	myosin filament	MYH1 MYH2 MYH4 MYH13	3.25e-07	25	49	4	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH2 MYH4 MYH13	5.23e-07	28	49	4	GO:0016460
GeneOntologyCellularComponent	actin cytoskeleton	MYH1 MYH2 MYH4 MYH13 XIRP2 MYO9B MYO10 ACKR2	5.27e-05	576	49	8	GO:0015629
GeneOntologyCellularComponent	myofibril	MYH1 MYH2 MYH4 MYH13 XIRP2	4.37e-04	273	49	5	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 MYH2 MYH4 MYH13 XIRP2	5.75e-04	290	49	5	GO:0043292
GeneOntologyCellularComponent	filopodium tip	MYO9B MYO10	9.95e-04	20	49	2	GO:0032433
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	7.90e-10	38	51	6	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	7.90e-10	38	51	6	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	7.90e-10	38	51	6	PF00063
Domain	MYSc	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	7.90e-10	38	51	6	SM00242
Domain	IQ	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	3.83e-08	71	51	6	PF00612
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH13	6.58e-08	15	51	4	PF02736
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH13	6.58e-08	15	51	4	IPR004009
Domain	IQ	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	8.50e-08	81	51	6	SM00015
Domain	Myosin_tail_1	MYH1 MYH2 MYH4 MYH13	1.47e-07	18	51	4	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH4 MYH13	1.47e-07	18	51	4	IPR002928
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	1.60e-07	90	51	6	IPR000048
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH4 MYH13	1.85e-07	19	51	4	IPR027401
Domain	-	MYH1 MYH2 MYH4 MYH13	1.85e-07	19	51	4	4.10.270.10
Domain	IQ	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	1.95e-07	93	51	6	PS50096
Domain	Dopey_N	DOP1A DOP1B	7.31e-06	2	51	2	IPR007249
Domain	Dopey_N	DOP1A DOP1B	7.31e-06	2	51	2	PF04118
Domain	P-loop_NTPase	MYH1 MYH2 MYH4 MYH13 MCM8 MYO9B MYO10 RASL11A RAD54B TAP1 ELP4	1.42e-05	848	51	11	IPR027417
Domain	Mob1_phocein	MOB1B MOB1A	1.52e-04	7	51	2	PF03637
Domain	MOB_kinase_act_fam	MOB1B MOB1A	1.52e-04	7	51	2	IPR005301
Domain	-	MOB1B MOB1A	1.52e-04	7	51	2	1.20.140.30
Domain	Mob1_phocein	MOB1B MOB1A	1.52e-04	7	51	2	SM01388
Domain	RA	MYO9B MYO10	4.34e-03	36	51	2	PF00788
Domain	RA_dom	MYO9B MYO10	5.34e-03	40	51	2	IPR000159
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH1 MYH2 MYH4 MYH13	2.05e-05	70	33	4	M12294
Pathway	KEGG_TIGHT_JUNCTION	MYH1 MYH2 MYH4 MYH13	2.43e-04	132	33	4	M11355
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4 MYH13	4.10e-12	4	51	4	10388558
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH4 MYH13	6.14e-11	6	51	4	10077619
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH4 MYH13	1.43e-10	7	51	4	35210422
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	2.97e-09	3	51	3	26059207
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	1.19e-08	4	51	3	11029314
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	1.19e-08	4	51	3	11023856
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	1.19e-08	4	51	3	18417546
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	2.96e-08	5	51	3	30737693
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH4	2.96e-08	5	51	3	3829126
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH4	2.96e-08	5	51	3	6196357
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4	2.96e-08	5	51	3	12919077
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	5.92e-08	6	51	3	20417199
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	5.92e-08	6	51	3	17559643
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH4	5.92e-08	6	51	3	1728586
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH4	5.92e-08	6	51	3	10588881
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH1 MYH2 MYH4	1.04e-07	7	51	3	29758057
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH2 MYH4	1.04e-07	7	51	3	16819597
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH1 MYH2 MYH4	1.65e-07	8	51	3	26993635
Pubmed	Cell lineage- and expression-based inference of the roles of forkhead box transcription factor Foxc2 in craniofacial development.	MYH1 MYH2 MYH4	1.65e-07	8	51	3	33667029
Pubmed	A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning.	MYH1 MYH2 MYH4	1.65e-07	8	51	3	14667415
Pubmed	GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics.	MYH1 MYH2 MYH4	2.48e-07	9	51	3	31960486
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH1 MYH2 MYH4	4.86e-07	11	51	3	18310078
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	MYH1 MYH2 MYH4	4.86e-07	11	51	3	38303699
Pubmed	The histone code reader Spin1 controls skeletal muscle development.	MYH1 MYH2 MYH4	4.86e-07	11	51	3	29168801
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH2 MYH4	4.86e-07	11	51	3	8136524
Pubmed	Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.	MYH1 MYH2 MYH4	4.86e-07	11	51	3	16024798
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH1 MYH2 MYH4	8.41e-07	13	51	3	8404542
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH1 MYH2 MYH4	1.07e-06	14	51	3	24938781
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH1 MYH2 MYH4	1.07e-06	14	51	3	27184118
Pubmed	Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation.	MYH1 MYH2 MYH4	1.07e-06	14	51	3	33742095
Pubmed	Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype.	MYH1 MYH2 MYH4	1.33e-06	15	51	3	24852826
Pubmed	MusTRD can regulate postnatal fiber-specific expression.	MYH1 MYH2 MYH4	1.64e-06	16	51	3	16494860
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH1 MYH2 MYH4	1.64e-06	16	51	3	19922871
Pubmed	IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism.	MYH1 MYH2 MYH4	1.99e-06	17	51	3	22351927
Pubmed	Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains.	MYH1 MYH4	2.11e-06	2	51	2	11150240
Pubmed	Myosin heavy chain composition of the human genioglossus muscle.	MYH1 MYH2	2.11e-06	2	51	2	22337492
Pubmed	Depletion of MOB1A/B causes intestinal epithelial degeneration by suppressing Wnt activity and activating BMP/TGF-β signaling.	MOB1B MOB1A	2.11e-06	2	51	2	30349003
Pubmed	Myosin heavy chains IIa and IId are functionally distinct in the mouse.	MYH1 MYH2	2.11e-06	2	51	2	9585413
Pubmed	Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.	MOB1B MOB1A	2.11e-06	2	51	2	23143302
Pubmed	Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling.	MYH2 MYH4	2.11e-06	2	51	2	21102503
Pubmed	Human Mob1 proteins are required for cytokinesis by controlling microtubule stability.	MOB1B MOB1A	2.11e-06	2	51	2	22454515
Pubmed	Analysis of mouse conceptuses with uniparental duplication/deficiency for distal chromosome 12: comparison with chromosome 12 uniparental disomy and implications for genomic imprinting.	MYH1 MYH2	2.11e-06	2	51	2	16575183
Pubmed	Different pathways regulate expression of the skeletal myosin heavy chain genes.	MYH1 MYH2	2.11e-06	2	51	2	11551968
Pubmed	Morphogenesis in Aspergillus nidulans requires Dopey (DopA), a member of a novel family of leucine zipper-like proteins conserved from yeast to humans.	DOP1A DOP1B	2.11e-06	2	51	2	10931277
Pubmed	Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle.	MYH1 MYH2	2.11e-06	2	51	2	7545970
Pubmed	Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice.	MYH1 MYH4	2.11e-06	2	51	2	11744674
Pubmed	Growth and muscle defects in mice lacking adult myosin heavy chain genes.	MYH1 MYH4	2.11e-06	2	51	2	9382868
Pubmed	Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis.	MYH1 MYH2 MYH4	2.39e-06	18	51	3	25753484
Pubmed	A new role for the calcineurin/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2/MyoD complex during mouse myogenesis.	MYH1 MYH2 MYH4	4.49e-06	22	51	3	24301466
Pubmed	EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.	MOB1B MOB1A	6.32e-06	3	51	2	34725466
Pubmed	Simultaneous loss of skeletal muscle myosin heavy chain IIx and IIb causes severe skeletal muscle hypoplasia in postnatal mice.	MYH1 MYH4	6.32e-06	3	51	2	36515178
Pubmed	Structural and developmental analysis of two linked myosin heavy chain genes.	MYH1 MYH2	6.32e-06	3	51	2	1371481
Pubmed	ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.	MYH2 MYH4	6.32e-06	3	51	2	23339872
Pubmed	The myosin alkali light chain proteins and their genes.	MYH2 MYH4	6.32e-06	3	51	2	3904738
Pubmed	Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles.	MYH2 MYH4	6.32e-06	3	51	2	8145163
Pubmed	The human tumour suppressor LATS1 is activated by human MOB1 at the membrane.	MOB1B MOB1A	6.32e-06	3	51	2	16674920
Pubmed	The expression of myosin heavy chain (MHC) genes in human skeletal muscle is related to metabolic characteristics involved in the pathogenesis of type 2 diabetes.	MYH1 MYH2	6.32e-06	3	51	2	21470888
Pubmed	Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle.	MYH2 MYH4	6.32e-06	3	51	2	15013776
Pubmed	Mon2, a relative of large Arf exchange factors, recruits Dop1 to the Golgi apparatus.	DOP1A DOP1B	6.32e-06	3	51	2	16301316
Pubmed	Molecular determinants of force production in human skeletal muscle fibers: effects of myosin isoform expression and cross-sectional area.	MYH1 MYH2	6.32e-06	3	51	2	25567808
Pubmed	PTEN-GSK3β-MOB1 axis controls neurite outgrowth in vitro and in vivo.	MOB1B MOB1A	1.26e-05	4	51	2	30069702
Pubmed	Three linked myosin heavy chain genes clustered within 370 kb of each other show independent transcriptional and post-transcriptional regulation during differentiation of a mouse muscle cell line.	MYH1 MYH4	1.26e-05	4	51	2	1985022
Pubmed	Non-muscle myosins 2A and 2B drive changes in cell morphology that occur as myoblasts align and fuse.	MYH2 SOX18	1.26e-05	4	51	2	16895968
Pubmed	Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein.	MOB1B MOB1A	1.26e-05	4	51	2	15197186
Pubmed	Evaluation of embryonic and perinatal myosin gene mutations and the etiology of congenital idiopathic clubfoot.	MYH1 MYH2	1.26e-05	4	51	2	20357587
Pubmed	Control of muscle formation by the fusogenic micropeptide myomixer.	MYH1 MYH2	1.26e-05	4	51	2	28386024
Pubmed	Human MYO18B, a novel unconventional myosin heavy chain expressed in striated muscles moves into the myonuclei upon differentiation.	MYH1 MYH4	1.26e-05	4	51	2	12547197
Pubmed	Deficiency of Myo18B in mice results in embryonic lethality with cardiac myofibrillar aberrations.	MYH1 MYH2	1.26e-05	4	51	2	18761673
Pubmed	Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism.	MYH1 MYH2 MYH4	1.30e-05	31	51	3	30081710
Pubmed	Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6.	MYH1 MYH2 MYH4	1.30e-05	31	51	3	21985497
Pubmed	Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development.	MYH1 MYH2 MYH4	1.57e-05	33	51	3	32094117
Pubmed	YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma.	MOB1B MOB1A	2.10e-05	5	51	2	32206709
Pubmed	Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice.	MYH1 MYH2	2.10e-05	5	51	2	29653945
Pubmed	Multigene family for sarcomeric myosin heavy chain in mouse and human DNA: localization on a single chromosome.	MYH1 MYH2	2.10e-05	5	51	2	6879174
Pubmed	Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice.	MYH1 MYH2	2.10e-05	5	51	2	17584907
Pubmed	Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.	LILRB2 TAP1	2.10e-05	5	51	2	11169396
Pubmed	Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease.	MYH1 MYH2 MYH4	2.62e-05	39	51	3	38690566
Pubmed	Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers.	MOB1B MOB1A	3.15e-05	6	51	2	35858357
Pubmed	YAP determines the cell fate of injured mouse hepatocytes in vivo.	MOB1B MOB1A	3.15e-05	6	51	2	28681838
Pubmed	Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice.	MOB1B MOB1A	3.15e-05	6	51	2	32716083
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH1 MYH2 MYH4 MYPOP MYH13 DPPA2 BEND3 PRPF8 NARS2 DOP1A	3.93e-05	1442	51	10	35575683
Pubmed	HOXA5 plays tissue-specific roles in the developing respiratory system.	MYH1 MYH2 MYH4	4.31e-05	46	51	3	28827394
Pubmed	Hox11-expressing interstitial cells contribute to adult skeletal muscle at homeostasis.	MYH1 MYH2	4.41e-05	7	51	2	36815629
Pubmed	Tails of unconventional myosins.	MYO9B MYO10	4.41e-05	7	51	2	11212352
Pubmed	PirB restricts ocular-dominance plasticity in visual cortex.	LILRB2 TAP1	4.41e-05	7	51	2	16917027
Pubmed	The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion.	MYH1 MYH2	4.41e-05	7	51	2	26586200
Pubmed	MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation.	MOB1B MOB1A	4.41e-05	7	51	2	18328708
Pubmed	Myomaker is a membrane activator of myoblast fusion and muscle formation.	MYH1 MYH2	4.41e-05	7	51	2	23868259
Pubmed	Mapping of unconventional myosins in mouse and human.	MYH4 MYO9B MYO10	4.90e-05	48	51	3	8884266
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH1 MYH2 MYH13 MOB1B MOB1A ACAD10 CDK14 MAP3K2	5.01e-05	910	51	8	36736316
Pubmed	Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene.	MYH1 MYH4	5.87e-05	8	51	2	3864153
Pubmed	Molecular characterization of human homologs of yeast MOB1.	MOB1B MOB1A	5.87e-05	8	51	2	19739119
Pubmed	Long noncoding RNA lncMREF promotes myogenic differentiation and muscle regeneration by interacting with the Smarca5/p300 complex.	MYH1 MYH4	5.87e-05	8	51	2	36200826
Pubmed	A Hoxa13:Cre mouse strain for conditional gene manipulation in developing limb, hindgut, and urogenital system.	MYH1 MYH2	5.87e-05	8	51	2	25980463
Pubmed	Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.	MOB1B MOB1A	5.87e-05	8	51	2	26699479
Pubmed	Genesis of muscle fiber-type diversity during mouse embryogenesis relies on Six1 and Six4 gene expression.	MYH1 MYH2 MYH4	8.66e-05	58	51	3	21884692
Pubmed	During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.	MYH1 MYH4	9.42e-05	10	51	2	19506036
Pubmed	Developmental origin and morphogenesis of the diaphragm, an essential mammalian muscle.	MYH1 MYH2	9.42e-05	10	51	2	29679560
Pubmed	Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice.	MYH1 MYH2	9.42e-05	10	51	2	8950513
Pubmed	Jaw muscularization requires Dlx expression by cranial neural crest cells.	MYH1 MYH2	1.15e-04	11	51	2	20534536
Interaction	RSPH6A interactions	MYH1 MYH2 MYH4 MYH13	1.36e-06	34	49	4	int:RSPH6A
Interaction	HSPB8 interactions	MYH1 MYH2 MYH4 MYO9B RICTOR TRIB1	3.65e-06	172	49	6	int:HSPB8
Interaction	LATS1 interactions	MYH1 MYH2 MYH4 MYH13 XIRP2 MOB1B MOB1A MAP3K2	9.97e-06	440	49	8	int:LATS1
Interaction	TSPAN33 interactions	MYH1 MYH2 MYH4 MYH13	1.87e-05	65	49	4	int:TSPAN33
Interaction	SLC39A3 interactions	MYH1 MYH2 MYH4 B3GNT2	2.51e-05	70	49	4	int:SLC39A3
Interaction	STK4 interactions	MYH1 MYH2 MYH13 MOB1B MOB1A	4.14e-05	159	49	5	int:STK4
Interaction	STK3 interactions	MYH1 MYH2 MYH13 MOB1B MOB1A	7.65e-05	181	49	5	int:STK3
Interaction	SBDS interactions	MYH1 MYH2 MYH4 MYH13 RASL11A	7.65e-05	181	49	5	int:SBDS
Interaction	ASAH2 interactions	MYH1 MYH4	8.63e-05	6	49	2	int:ASAH2
Interaction	BPNT1 interactions	MCM8 MYO9B ACAD10 NARS2	8.69e-05	96	49	4	int:BPNT1
Interaction	ABTB2 interactions	MYH1 MYH2 MYH4 RICTOR	1.06e-04	101	49	4	int:ABTB2
Interaction	CDK3 interactions	MYH1 MYH2 MYH13 B3GNT2	1.69e-04	114	49	4	int:CDK3
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	MYH1 MYH2 MYH4 MYH13 AIPL1 PRPF8	2.37e-06	346	51	6	chr17p13
Cytoband	17p13.1	MYH1 MYH2 MYH4 AIPL1	9.44e-06	118	51	4	17p13.1
Cytoband	11p15.4	OR52E8 OR52E5 ZNF214	1.45e-03	200	51	3	11p15.4
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH4 MYH13	2.48e-08	15	39	4	1098
GeneFamily	MOB kinase activators\|STRIPAK complex	MOB1B MOB1A	9.46e-05	7	39	2	647
GeneFamily	Olfactory receptors, family 52	OR52E8 OR52E5	5.00e-03	49	39	2	165
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4	7.28e-06	20	50	3	M1123
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4	8.48e-06	21	50	3	MM1102
Coexpression	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP	GLT8D2 ZNF214 ACKR2 TAP1 ELP4	3.58e-05	196	50	5	M5313
Coexpression	GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	SLFN12L MYO10 MOB1B ITGB1BP1 B3GNT2	3.94e-05	200	50	5	M7271
Coexpression	GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN	SLFN12L MARCHF5 ITGB1BP1 TAP1 MAP3K2	3.94e-05	200	50	5	M9081
Coexpression	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN	SLFN12L TCOF1 MARCHF5 B3GNT2 TAP1	3.94e-05	200	50	5	M3638
Coexpression	GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN	SLFN12L MYO10 MOB1B DPPA2 MAP3K2	3.94e-05	200	50	5	M4108
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)\|Thalamus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 MYH4 MYH13	1.86e-06	77	51	4	7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5
ToppCell	Biopsy_Control_(H.)-Endothelial-Lymphatic_Endothelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	GLT8D2 STK32B SOX18 PGAP4 ACKR2	3.28e-06	200	51	5	8cf218887ab030b7625610cb65b595170a17ebec
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH13 STK32B	1.28e-05	125	51	4	d05556ea185c15815a4f8643f1c01185badbeece
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH13 STK32B	2.24e-05	144	51	4	71107275767a0728541a3695715c44874b3e5efc
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH13 STK32B	2.43e-05	147	51	4	50e86860a94be103092c40e39a172eac92372f0d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH13 STK32B	3.38e-05	160	51	4	0bfdaf979e6f128cba2928ce16bca4d3deff8ac9
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	PRTG XIRP2 LILRB2 TAP1	3.72e-05	164	51	4	362c16ed7fb37bf16601fd5e059d3f3e2ed692b4
ToppCell	Endothelial-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	GLT8D2 STK32B SOX18 ACKR2	3.90e-05	166	51	4	c286987ea4e511195607c87ec4529c2c2ed2122e
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH1 MYH4 XIRP2 RAD54B	3.99e-05	167	51	4	d78356bf0c473816dbabaee51984940bd822f84e
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH13 STK32B	4.28e-05	170	51	4	8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH2 MYH4 XIRP2	4.69e-05	174	51	4	4a6e04b4f12b87c15fa1409989cbe32c43736369
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH1 MYH4 MYH13	4.95e-05	62	51	3	a20620a8869721ea62984c2022ee1b484b455824
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH1 MYH4 MYH13	4.95e-05	62	51	3	ee694c06bcd924b4ddf744178ba3a99e04eed51b
ToppCell	(6)_Endothelial-F_(Lymphatics)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	STK32B SOX18 PGAP4 ACKR2	5.82e-05	184	51	4	03ea613e00b45c81b752c14505a0538d698f551e
ToppCell	343B-Endothelial_cells-Endothelial-F_(Lymphatics)\|343B / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 STK32B PGAP4 ACKR2	6.07e-05	186	51	4	7a8da2ad140bea3207bd868212cc5e201d586772
ToppCell	343B-Endothelial_cells-Endothelial-F_(Lymphatics)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 STK32B PGAP4 ACKR2	6.07e-05	186	51	4	dc394034929c6b10ae0e1c1a028cc3d4ce873298
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH1 MYH2 MYH4 MYH13	6.07e-05	186	51	4	bdc87e4631a8ea73e262e541aa84a28f24c94b00
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 STK32B PGAP4 ACKR2	6.33e-05	188	51	4	1f40b959777d18ad88d239df8cca304f062ba04c
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)\|390C / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 STK32B PGAP4 ACKR2	6.33e-05	188	51	4	aa69e3f44d506f5ef358a3374ac5160d847c858f
ToppCell	COVID-19-Heart-Mito_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH1 MYH2 XIRP2 SOX18	6.59e-05	190	51	4	ea74e0e38bcaba125b48c88331e9ba09228d3178
ToppCell	367C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 STK32B PGAP4 ACKR2	6.87e-05	192	51	4	5f4f44f15d3a2846981e68296643a4634930a211
ToppCell	367C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 STK32B PGAP4 ACKR2	6.87e-05	192	51	4	5e709c0714e8eba27e03a6def0544256bedb3ced
ToppCell	PBMC-Mild\|PBMC / Compartment, Disease Groups and Clusters	TCOF1 RICTOR TAP1 MAP3K2	7.15e-05	194	51	4	d1366b169d14011194e61d16b6b0953349febc78
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	SLFN12L B3GNT2 TAP1 DOP1A	7.29e-05	195	51	4	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	343B-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 STK32B PGAP4 ACKR2	7.29e-05	195	51	4	fc75f04eb475c8139cc5c35e6be22e73fb2be9e6
ToppCell	343B-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 STK32B PGAP4 ACKR2	7.29e-05	195	51	4	83d45ff5e5bc704448431149fffb2e4c1278f279
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	SLFN12L B3GNT2 TAP1 DOP1A	7.44e-05	196	51	4	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	(1)_T_cell-(15)_Treg\|(1)_T_cell / shred on Cell_type and subtype	B3GNT2 ACKR2 CDK14 TRIB1	7.58e-05	197	51	4	6e7723e8b977be35c60cc11ac7cfa4f71339441e
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	GLT8D2 ITGB1BP1 PGAP4 ACKR2	7.73e-05	198	51	4	7a99c341736a4a2ac48ef8e2f7951f21a7378946
ToppCell	medial-Endothelial-Lymphatic-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GLT8D2 STK32B PGAP4 ACKR2	7.73e-05	198	51	4	41983d405215b974044e2e9e6c212b134336a6fe
ToppCell	medial-2-Endothelial-Lymphatic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GLT8D2 STK32B PGAP4 ACKR2	7.73e-05	198	51	4	e4274584512a72270087a1ab104fab449a2f83bc
ToppCell	medial-Endothelial-Lymphatic\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GLT8D2 STK32B PGAP4 ACKR2	7.73e-05	198	51	4	1760fede363544bc0fa2e22fe36aff522abd2525
Drug	formycin triphosphate	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	1.37e-09	51	50	6	CID000122274
Drug	purealin	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	3.05e-09	58	50	6	CID006419303
Drug	S-(-)-Etomoxir	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	8.38e-08	100	50	6	CID000060765
Drug	blebbistatin	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	2.03e-07	116	50	6	CID003476986
Drug	B0683	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	2.14e-07	117	50	6	CID006398969
Drug	clenbuterol	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	6.71e-07	142	50	6	CID000002783
Drug	fast white	MYH1 MYH2 MYH4 MYH13	2.17e-06	42	50	4	CID000024008
Drug	NSC107658	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10 CDK14	4.50e-06	306	50	7	CID000002919
Drug	4-chloroaniline	MYH1 MYH2 MYH4 MYH13 MYO10 RASL11A	5.20e-06	202	50	6	CID000007812
Drug	AC1NRBPQ	MYH1 MYH2 MYH4 MYH13 MYO10	1.25e-05	137	50	5	CID005288569
Drug	eye gene	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10 DBH	1.52e-05	369	50	7	CID000004782
Drug	candesartan cilexetil	MYH1 MYH2 MYH4 MYH13 TAP1	1.64e-05	145	50	5	CID000002540
Drug	NSC339663	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	1.75e-05	250	50	6	CID000003892
Drug	SM-2	MYH1 MYH2 MYH4 MYH13	4.00e-05	87	50	4	CID000486033
Drug	sodium dodecyl sulfate	MYH1 MYH4 TCOF1 MYO10	4.78e-05	91	50	4	CID000008778
Drug	AC1L1IZ2	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	5.23e-05	304	50	6	CID000004795
Drug	creatine	MYH1 MYH2 MYH4 MYH13 PHIP	6.46e-05	193	50	5	CID000000586
Drug	Aminocaproic acid [60-32-2]; Up 200; 30.4uM; MCF7; HT_HG-U133A	MYH2 LILRB2 PGAP4 ACKR2 H6PD	6.95e-05	196	50	5	6501_UP
Drug	trifluoperazine	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	7.44e-05	324	50	6	CID000005566
Drug	Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A	MYH2 LILRB2 ACKR2 H6PD CDK14	7.65e-05	200	50	5	2788_UP
Drug	nocodazole	MYH1 MYH2 MYH4 MYH13 MOB1B MOB1A CDK14	7.77e-05	477	50	7	CID000004122
Drug	NSC611747	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	1.17e-04	352	50	6	CID000002534
Drug	N-ethylmaleimide	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10 DBH	1.19e-04	511	50	7	CID000004362
Drug	MgCl2	MYH1 MYH2 MYH4 MYH13 MYO9B MYO10	1.21e-04	354	50	6	CID000024584
Drug	m396	DBH TAP1	1.31e-04	8	50	2	CID000098969
Drug	oxovanadium	MYH1 MYH2 MYH4 MYH13	1.40e-04	120	50	4	CID000024411
Drug	2bq7	MYH1 MYH2 MYH4 MYH13	1.54e-04	123	50	4	CID006540267
Drug	AC1LADJ6	MYH1 MYH2 MYH4 MYH13	1.91e-04	130	50	4	CID000486032
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.52e-09	10	50	4	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.52e-09	10	50	4	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.52e-09	10	50	4	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.52e-09	10	50	4	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.52e-09	10	50	4	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.52e-09	10	50	4	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.52e-09	10	50	4	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.52e-09	10	50	4	DOID:0111596 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	3.57e-09	12	50	4	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	3.57e-09	12	50	4	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	5.16e-09	13	50	4	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	9.82e-09	15	50	4	DOID:0050646 (implicated_via_orthology)
Disease	myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.34e-06	48	50	4	DOID:423 (implicated_via_orthology)
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	6.52e-06	71	50	4	DOID:0050700 (implicated_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH13	1.05e-05	80	50	4	DOID:12930 (implicated_via_orthology)
Disease	aspirin use measurement	TDRD15 ACAD10 TRIB1	4.01e-05	39	50	3	EFO_0007013
Disease	Down syndrome (implicated_via_orthology)	DOP1A DOP1B	2.91e-04	15	50	2	DOID:14250 (implicated_via_orthology)
Disease	low density lipoprotein triglyceride measurement	TDRD15 TRIB1	2.91e-04	15	50	2	EFO_0009946
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	TDRD15 TRIB1	4.23e-04	18	50	2	EFO_0008317, EFO_0008589
Disease	Hypertriglyceridemia	TDRD15 TRIB1	4.72e-04	19	50	2	EFO_0004211
Disease	mean corpuscular hemoglobin concentration	MYH2 MYPOP MYO9B MOB1B B3GNT2 BEND3 ACAD10 TRIB1	5.00e-04	1105	50	8	EFO_0004528
Disease	anti-Mullerian hormone measurement	MYH4 MCM8	5.24e-04	20	50	2	EFO_0004769
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	TDRD15 MYH2 MYPOP TRIB1	5.48e-04	222	50	4	EFO_0008317, EFO_0020943
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TDRD15 MYH2 MYPOP TRIB1	7.22e-04	239	50	4	EFO_0008317, EFO_0020945
Disease	C-X-C motif chemokine 10 measurement	MYH2 MYPOP MOB1B	8.47e-04	109	50	3	EFO_0008056
Disease	macular telangiectasia type 2	TRIB1 ELP4	8.91e-04	26	50	2	EFO_1002009
Disease	factor VIII measurement, coronary artery disease	TDRD15 ACAD10 TRIB1	9.40e-04	113	50	3	EFO_0001645, EFO_0004630
Disease	factor XI measurement, coronary artery disease	TDRD15 MYH13 TRIB1	9.89e-04	115	50	3	EFO_0001645, EFO_0004694
Disease	Large cell carcinoma of lung	TRIB1 MAP3K2	1.35e-03	32	50	2	C0345958
Disease	free cholesterol in small HDL measurement	TDRD15 TRIB1	1.62e-03	35	50	2	EFO_0022270
Disease	cholesteryl esters to total lipids in very large HDL percentage	TDRD15 TRIB1	1.71e-03	36	50	2	EFO_0022257
Disease	osteoarthritis, hand	MYH2 MYPOP	1.80e-03	37	50	2	EFO_1000789
Disease	free cholesterol to total lipids in large VLDL percentage	TDRD15 TRIB1	1.80e-03	37	50	2	EFO_0022281
Disease	reticulocyte measurement	SLFN12L MYO9B BEND3 RICTOR PRPF8 TRIB1 NARS2	1.89e-03	1053	50	7	EFO_0010700
Disease	cholesterol in very small VLDL measurement	TDRD15 TRIB1	2.11e-03	40	50	2	EFO_0022231
Disease	free cholesterol in medium LDL measurement	TDRD15 TRIB1	2.11e-03	40	50	2	EFO_0022268
Disease	retinitis pigmentosa (is_implicated_in)	AIPL1 PRPF8	2.21e-03	41	50	2	DOID:10584 (is_implicated_in)
Disease	triglycerides in large LDL measurement	TDRD15 TRIB1	2.43e-03	43	50	2	EFO_0022319
Disease	suicide behaviour measurement	STK32B DPPA2	2.43e-03	43	50	2	EFO_0006882
Disease	concentration of large LDL particles measurement	TDRD15 TRIB1	2.54e-03	44	50	2	EFO_0022160
Disease	cholesterol in medium VLDL measurement	TDRD15 TRIB1	2.54e-03	44	50	2	EFO_0022225

Protein segments in the cluster

Peptide	Gene	Start	Entry
DKYLEIVHAQPYHRL	ACKR2	141	O00590
ILRHHPGIVKAYYVR	AIPL1	256	Q9NZN9
LRPHDIAYLLVYRKH	ADAM18	266	Q9Y3Q7
LYHRLKHFMEQRVYP	ACAD10	666	Q6JQN1
NIHPLYQHVLLYLQL	DOP1A	1361	Q5JWR5
YIHQRYILHRDLKPQ	CDK14	246	O94921
YLVYHLRPHQKEGII	RAD54B	291	Q9Y620
IKLIRHYVQLLYPRA	BEND3	611	Q5T5X7
HYVQLLYPRAKNDRV	BEND3	616	Q5T5X7
IPHQLLRKYIGYARQ	MCM8	661	Q9UJA3
KHILLYLQPYDSRRV	DOP1B	1226	Q9Y3R5
HLHEPAVLYNLKERY	MYH2	96	Q9UKX2
RKYTRQILEGVHYLH	MAP3K2	461	Q9Y2U5
IYKRNPILRYTHHPL	MYO10	1526	Q9HD67
LRLRSIHEYPKYQAE	LILRB2	366	Q8N423
YLRQAHRKILNYPEQ	MARCHF5	261	Q9NX47
YLPLLIHQHEKVIYL	GLT8D2	141	Q9H1C3
HLHEPAVLYNLKERY	MYH1	96	P12882
ILKRLFRVYAHIYHQ	MOB1B	151	Q7L9L4
LYLKLYHPERLQHYI	PGAP4	241	Q9BRR3
ILHLLNHPKTRQYVR	RICTOR	231	Q6R327
DPRRKYHVRLLAYNN	PRTG	681	Q2VWP7
HYFLRKLRIHLTPYI	EFCAB6	1111	Q5THR3
RYLRLEVHYHNPLVI	DBH	326	P09172
YKDYHGLIHIRQIPR	ELP4	341	Q96EB1
LQAHLLQHVRIPYYN	H6PD	636	O95479
IEVYLRLHRHAYPEQ	DPPA2	116	Q7Z7J5
QYDVLHRHALYLIIR	ITGB1BP1	126	O14713
NIPHYIHILLANLYV	OR52E5	266	Q8NH55
HNIPQYIHIILANLY	OR52E8	271	Q6IFG1
YLSIRPLYQHIRKVH	RASL11A	121	Q6T310
PYVHNKLLLYRTRKQ	PTAR1	66	Q7Z6K3
IIYALVIIHPNHLYN	TDRD15	901	B5MCY1
LPLIYHHLLRAGYVR	TCOF1	11	Q13428
KERHPLEYLRQYPHF	NARS2	131	Q96I59
ILKRLFRVYAHIYHQ	MOB1A	151	Q9H8S9
GKPLPQYEHRYLHRQ	TAP1	566	Q03518
HLHEPAVLYNLKERY	MYH4	96	Q9Y623
ALRLYHITDQVHLYP	B3GNT2	316	Q9NY97
LLIHRKNLNYLHLDY	PRPF8	506	Q6P2Q9
YELNRLYKHIHPELR	XIRP2	321	A4UGR9
HYQDKIRPYIQLPSH	TRIB1	126	Q96RU8
QNLVKYYRHLAPDHL	PHIP	61	Q8WWQ0
REYINFKIQPLRYHL	SLFN12L	386	Q6IEE8
DLHNLNKRIRYLYKH	MRPL51	106	Q4U2R6
HLHEPAVLYNLKERY	MYH13	96	Q9UKX3
LRVQHLRDHPNYKYR	SOX18	141	P35713
ALALEYLQRYHIIHR	STK32B	131	Q9NY57
YLQRYHIIHRDIKPD	STK32B	136	Q9NY57
VLAHPRYLQHHIKYQ	ZFP91	321	Q96JP5
DLYRHPRNHIGKKLY	ZNF214	261	Q9UL59
RREQAAYHLHIYPQL	MYO9B	11	Q13459
QILIREVRAHYPQLY	MYPOP	26	Q86VE0